These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32894953)

  • 1. Integrated dia-gnostics of diffuse gliomas.
    Hendrych M; Valeková H; Kazda T; Lakomý R; Šána J; Jančálek R; Slabý O; Hermanová M
    Klin Onkol; 2020; 33(4):248-259. PubMed ID: 32894953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.
    Rogers TW; Toor G; Drummond K; Love C; Field K; Asher R; Tsui A; Buckland M; Gonzales M
    J Neurooncol; 2018 Mar; 137(1):181-189. PubMed ID: 29218432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.
    Onizuka H; Masui K; Komori T
    Int J Clin Oncol; 2020 Jun; 25(6):997-1003. PubMed ID: 32468200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
    Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
    Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular Diagnostic Approaches for Diffuse Gliomas Based on Updated WHO Classification and cIMPACT-NOW Proposals].
    Masui K; Komori T
    No Shinkei Geka; 2021 May; 49(3):510-519. PubMed ID: 34092556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO 2016 Classification of gliomas.
    Wesseling P; Capper D
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):139-150. PubMed ID: 28815663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis to complement histopathological diagnosis of brain tumors.
    Nakamura M; Shimada K; Ishida E; Nakase H; Konishi N
    Histol Histopathol; 2007 Mar; 22(3):327-35. PubMed ID: 17163407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?
    Weller M; Reifenberger G
    Curr Opin Neurol; 2020 Dec; 33(6):701-706. PubMed ID: 33177376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The 2021 WHO Classification of Tumors, 5th edition, Central Nervous System Tumors: A Short Review].
    Komori T
    Brain Nerve; 2022 Jun; 74(6):803-809. PubMed ID: 35676215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The 2021 WHO classification of tumours of the central nervous system].
    Figarella-Branger D; Appay R; Metais A; Tauziède-Espariat A; Colin C; Rousseau A; Varlet P
    Ann Pathol; 2022 Oct; 42(5):367-382. PubMed ID: 34865882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controversy in the Postoperative Treatment of Low-grade Gliomas].
    Kazda T; Lakomý R; Poprach A; Pospíšil P; Jančálek R; Šlampa P
    Klin Onkol; 2017; 30(5):337-342. PubMed ID: 29031035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Cell Leukemia –  the Forgotten Dis­ease.
    Žárska M; Vrábel D; Bezdekova R; Štork M; Jarošová M; Adam Z; Krejčí M; Pour L; Ševčíková S
    Klin Onkol; 2019; 32(1):40-46. PubMed ID: 30764628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant Tumors of the Penis - Dia-gnostics and Therapy.
    Mrinakova B; Ondrušová M; Švantnerová M; Ondruš D
    Klin Onkol; 2019; 32(1):31-39. PubMed ID: 30764627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].
    Ortega-Aznar A; Jimenez-Leon P; Martinez E; Romero-Vidal FJ
    Rev Neurol; 2013 Feb; 56(3):161-70. PubMed ID: 23359078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Essentials of Molecular Testing in CNS Tumors: What to Order and How to Integrate Results.
    Feldman AZ; Jennings LJ; Wadhwani NR; Brat DJ; Horbinski CM
    Curr Neurol Neurosci Rep; 2020 May; 20(7):23. PubMed ID: 32445025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.
    Perez A; Huse JT
    Curr Neurol Neurosci Rep; 2021 Nov; 21(12):67. PubMed ID: 34817712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Tumor Size and p16 Status on Treatment Outcomes - Achievement of Complete Remission in Prospectively Followed Patients with Oropharyngeal Tumors.
    Slavik M; Kazda T; Selingerová I; Šána J; Ahmad P; Gurín D; Hermanová M; Novotný T; Červená R; Dymáčková R; Burkoň P; Slabý O; Šlampa P
    Klin Onkol; 2019; 32(1):58-65. PubMed ID: 30764631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult Diffuse Astrocytic and Oligodendroglial Tumors.
    Gestrich CK; Couce ME; Cohen ML
    Neurosurgery; 2021 Oct; 89(5):737-749. PubMed ID: 33611566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Role of Chemotherapy in the Treatment of Low-grade Gliomas].
    Lakomý R; Kazda T; Poprach A; Pospíšil P; Jančálek R; Šlampa P
    Klin Onkol; 2017; 30(5):343-348. PubMed ID: 29031036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.